0001127602-16-062828.txt : 20160919 0001127602-16-062828.hdr.sgml : 20160919 20160919172139 ACCESSION NUMBER: 0001127602-16-062828 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160916 FILED AS OF DATE: 20160919 DATE AS OF CHANGE: 20160919 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ehrich Elliot CENTRAL INDEX KEY: 0001376548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 161892479 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-09-16 0001520262 Alkermes plc. ALKS 0001376548 Ehrich Elliot 852 WINTER ST. WALTHAM MA 02451 1 EVP, R&D & CMO, Alkermes, Inc. Ordinary Shares 2016-09-16 4 M 0 5000 18.105 A 50311 D Ordinary Shares 2016-09-16 4 S 0 5000 48.8661 D 45311 D Employee Stock Option (Right to Buy) 18.105 2016-09-16 4 M 0 5000 0 D 2021-05-20 Ordinary Shares 5000 31000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.80 to $49.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for Elliot Ehrich 2016-09-19